Skip to main content
Top
Published in: Endocrine 1/2007

01-02-2007 | Original Paper

The effects of glutamate can be attenuated by estradiol via estrogen receptor dependent pathway in rat adrenal pheochromocytoma cells

Authors: Ching-Rong Chan, Jih-Tay Hsu, I.-tea Chang, Y.-C. Young, Chun-Ming Lin, Chingwen Ying

Published in: Endocrine | Issue 1/2007

Login to get access
Metadata
Title
The effects of glutamate can be attenuated by estradiol via estrogen receptor dependent pathway in rat adrenal pheochromocytoma cells
Authors
Ching-Rong Chan
Jih-Tay Hsu
I.-tea Chang
Y.-C. Young
Chun-Ming Lin
Chingwen Ying
Publication date
01-02-2007
Publisher
Humana Press Inc
Published in
Endocrine / Issue 1/2007
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-007-0010-2

Other articles of this Issue 1/2007

Endocrine 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine